Clinquest

What Clinquest does

Clinquest is described in available firmographic data as a US-based, for-profit healthcare product development company operating as a specialty contract and service provider, headquartered in Hudson with 11-50 employees. The bulk of the available source material, however, describes an affiliated or overlapping global CRO (Linical Co., Ltd.) offering drug development strategy, full-service clinical trial management, and a flagship medical affairs and pharmacovigilance service line established in 2005. The CRO segment serves pharmaceutical, biotechnology, and medical device companies across Japan, the United States, and Europe, with therapeutic expertise spanning oncology, neurology and psychiatry, immunology and vaccine, and endocrinology and metabolic conditions.

The company's core technology stack centers on a 21 CFR Part 11 validated and compliant global safety database used for pharmacovigilance case processing and automated regulatory report generation (MedWatch 3500A, CIOMS I). This safety infrastructure has been augmented through the integration of LifeSphere, a third-party AI and robotic process automation platform, applied to adverse event reporting workflows and case processing. Service delivery spans drug development strategy (protocol design, regulatory consulting, quality assurance, medical writing), clinical trial management (feasibility, project management, clinical monitoring, patient recruitment, biometrics, training academy), medical affairs and pharmacovigilance, and complementary medical information services including call center, social media monitoring, and product recall planning.

The business model is professional-services-based with custom-quoted engagements. Go-to-market is executed through direct enterprise sales, with prospects requesting proposals and receiving personalized plans executed by dedicated project teams. The firm claims a nearly 90% client retention rate. Pricing is not publicly disclosed and is tailored to project requirements. Customer segments are horizontally defined across pharmaceutical companies, biotechnology companies, and medical device companies, with no named customer logos available in the source data to triangulate revenue concentration or contract value.

Name

Clinquest

Legal name

Linical Co., Ltd.

Website

https://clinquest.com

Company type

Public

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Clinquest is described as a US-based specialty contract and service provider in healthcare product development, with related source data describing a global CRO offering clinical trial management, medical affairs, and pharmacovigilance services to pharmaceutical, biotechnology, and medical device companies across Japan, the US, and Europe.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Contract research organization
• Pharmacovigilance services
• Clinical trial management
• Drug development consulting
• Medical affairs services

Headquarters

HQ city

Hudson

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Trial Management Services: Full-service CRO offerings including medical affairs, pharmacovigilance, clinical monitoring, project management, biometrics, and patient recruitment services for pharmaceutical and biotech companies conducting clinical trials
2. Pharmacovigilance Services: Drug safety management including clinical surveillance, postmarketing surveillance, adverse event reporting, and regulatory compliance services for drugs and medical devices
3. Medical Information Services: Medical information call center, product inquiry response, adverse event intake, and social media monitoring for drug safety

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Clinquest provides end-to-end clinical research and drug development services to pharmaceutical and biotechnology companies, including protocol design, regulatory consulting, clinical monitoring, patient recruitment, biometrics, medical writing, and postmarketing pharmacovigilance. The company combines therapeutic expertise with a 21 CFR Part 11 validated safety database and LifeSphere AI/RPA automation to deliver compliant safety data processing and automated regulatory reporting across clinical and postmarketing phases.

Product overview

Linical operates as a global CRO offering an integrated platform of drug development and clinical research services. The core offering combines Drug Development Strategy services (protocol development, regulatory consulting, quality assurance, medical writing) with Clinical Trial Management capabilities (monitoring, patient recruitment, biometrics). The Medical Affairs & Pharmacovigilance service is a flagship offering since 2005, providing end-to-end safety management for clinical and postmarketing drugs and devices. Medical Information Services provide complementary consumer-facing support including complaint intake and inquiry management. The company leverages LifeSphere, an AI-powered technology platform, to enhance pharmacovigilance case processing with robotic process automation.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Development Strategy Comprehensive consulting services including protocol development and study design, regulatory consulting, regulatory affairs, quality assurance, and medical writing to guide drug development from early stages through approval. Targeted at pharmaceutical and biotechnology companies.
• Clinical Trial Management Full-service clinical trial management encompassing feasibility and study startup, project management, medical affairs and pharmacovigilance, clinical monitoring, patient recruitment, biometrics, and training academy. Targeted at pharmaceutical and biotechnology companies conducting clinical trials from early-phase through large-scale global studies.
• Medical Affairs & Pharmacovigilance

Quantifiable outcome

• Nearly 90% client retention rate
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Scale indicators4 records

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• IQVIA: Largest global full-service CRO offering clinical trial management, pharmacovigilance, and real-world evidence; competes for the same pharma/biotech RFPs but with vastly broader service portfolio and scale.
• ICON plc: Major global CRO with full-service clinical operations and post-marketing/PV capabilities; directly comparable CRO service lines and similar sponsor target market.
• Parexel International: Large global CRO with strong pharmacovigilance, regulatory, and clinical monitoring services; competes in the same pharma/biotech sponsor segment with broader scale.
• Fortrea (formerly Labcorp Drug Development): Full-service CRO spun out of Labcorp with end-to-end clinical development and safety services; broad incumbent competing for similar enterprise CRO engagements.
• Syneos Health: Global CRO offering clinical development, pharmacovigilance, and commercialization services; comparable full-service model and biopharma sponsor base.
• Charles River Laboratories: Large CRO/preclinical services provider with growing clinical and safety service lines; adjacent comparable in the contract research services space serving similar pharma/biotech clients.

Direct peers

• Medpace Holdings: Mid-sized global CRO with full-service clinical trial management across multiple therapeutic areas; comparable size and operating model targeting biotech and mid-pharma sponsors.
• Worldwide Clinical Trials: Mid-sized global CRO focused on clinical trial management across therapeutic areas; closely comparable mid-market CRO peer with similar sponsor mix.
• Clinipace Worldwide: Smaller full-service CRO offering clinical trial management and biostatistics to mid-sized biopharma; comparable scale and CRO service mix.
• Theorem Clinical Research: Mid-sized CRO with full-service clinical and PV offerings; comparable service scope and target market of small-to-mid biopharma sponsors.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clinquest-inc.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinquest